Lars Weiss
Researcher
Diabetes and Endocrinology
Stockholm Health Economics
Sweden
Biography
Lars Weiss is a researcher in both Internal Medicine and in Clinical diabetes and endocrinology in Stockholm Health Economics, Stockholm, Sweden.
Research Interest
Lars Weiss research involves in demonstrated that co-administration of losartan, an angiotensin-II-receptor antagonist, with existing conventional antihypertensive therapy (CT) reduces the risk of development of end-stage renal disease (ESRD) in type 2 diabetes patients with nephropathy compared with CT alone.
